Therapy for stage IIIB and stage IV non-small cell lung cancer-Reference-Cited by-同舟云学术

Therapy for stage IIIB and stage IV non-small cell lung cancer

Published:2002-03 Issue:1 Volume:23 Page:209-224
ISSN:0272-5231
Container-title:Clinics in Chest Medicine
language:en
Short-container-title:Clinics in Chest Medicine

Author:

Kim Tracy E,Murren John R

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine

Reference211 articles.

1. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: Aphase II study;Abratt;J Clin Oncol,1994

2. A phase I trial of the farnesyl transferase inhibitor R115777, in combinationwith gemcitabine and cisplatin in patients with advanced cancer;Adjei;PASCO,2001

3. Phase I study of BMS-188797, a new taxane analog administered weekly inpatients with advanced malignancies;Advani;PASCO,2001

4. Phase I trial of weekly paclitaxel in advanced lung cancer;Akerley;J Clin Oncol,1998

5. Single agent taxol, 3-hour infusion, in untreated advanced non-small-celllung cancer;Alberola;Ann Oncol,1995

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics models predict treatment response and overall survival for non-small cell lung cancer patients following chemo-radiotherapy: A multi-center study;2024-03-13

2. Multi-Omics Models Predict Prognosis for Non-Small Cell Lung Cancer Patients Followed Chemotherapy and Radiotherapy: A Multi-Center Study;2024

3. Physician attitudes and prevalence of molecular testing in lung cancer;The Journal of Community and Supportive Oncology;2017-05

4. Advances in the prevention and treatment of lung cancer;The Journal of the Royal College of Physicians of Edinburgh;2011-06-01

5. Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age ≤65 and performance status 2;Lung Cancer;2006-06